Yet more price cuts announced yesterday to come into effect on 1 October for 300 medicines reaffirms that the Pharmaceutical Benefits Scheme is sustainable.

“We have been saying for a long time that these cuts will continue and, frankly, it’s no surprise. Some arguments that have been made about generic medicine pricing are clearly outdated,” Dr Brendan Shaw, Medicines Australia Chief Executive, said.

Generic medicines on the PBS will see price cuts of up to 62 per cent on October 1 when the first round of simplified price disclosure takes effect.

“The key issue for the PBS now is access to new medicines.

For more details, go to: http://medicinesaustralia.com.au/2014/06/20/price-cuts-mean-pbs-is-sustainable-and-can-afford-new-medicines/#more-12026